Boston Biochem

Boston Biochem

Biotechnology, 840 Memorial Dr Ste 3, Cambridge, Massachusetts, 02139, United States, 11-50 Employees

bostonbiochem.com

  • LinkedIn

phone no Phone Number: +16*********

Who is BOSTON BIOCHEM

Boston Biochem, Inc. is the leading global producer of ubiquitin-related research products. Since 1997, it has been our mission to provide ubiquitin proteasome pathway (UPP) researchers w...

Read More

map
  • 840 Memorial Dr Ste 3, Cambridge, Massachusetts, 02139, United States Headquarters: 840 Memorial Dr Ste 3, Cambridge, Massachusetts, 02139, United States
  • 1997 Date Founded: 1997
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541711 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BOSTON BIOCHEM

Boston Biochem Org Chart and Mapping

Employees

Similar Companies to Boston Biochem

Bio-Techne

  • 1001-5000 1001-5000
  • 1 Billion and Over $ 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Boston Biochem

Answer: Boston Biochem's headquarters are located at 840 Memorial Dr Ste 3, Cambridge, Massachusetts, 02139, United States

Answer: Boston Biochem's phone number is +16*********

Answer: Boston Biochem's official website is https://bostonbiochem.com

Answer: Boston Biochem's revenue is $1 Million to $5 Million

Answer: Boston Biochem's SIC: 2836

Answer: Boston Biochem's NAICS: 541711

Answer: Boston Biochem has 11-50 employees

Answer: Boston Biochem is in Biotechnology

Answer: Boston Biochem top competitors include: Bio-Techne

Answer: Boston Biochem contact info: Phone number: +16********* Website: https://bostonbiochem.com

Answer: Boston Biochem, Inc. is the leading global producer of ubiquitin-related research products. Since 1997, it has been our mission to provide ubiquitin proteasome pathway (UPP) researchers with innovative tools that facilitate and accelerate drug discovery efforts. Boston Biochem specializes in several related product lines for ubiquitin and ubiquitin-like (UBL) proteins (e.g. Apg8, FAT10, ISG15, NEDD8, SUMO, UFM1) and associated enzymes, substrates, inhibitors and kits. In 2011, Boston Biochem was acquired by TECHNE Corporations R&D Systems, a leading supplier of cell biology reagents with more than 20 years of experience and a unique product manufacturing model that ensures strict quality control and the highest level of consistency and performance in their products. With R&D Systems expertise in sales, distribution and logistics in place, Boston Biochem is now exclusively focused on new product development. Extensive expertise in protein purification, characterization, modification and assay development as well as a close relationship with the UPP research community allows us to continue to offer the most comprehensive product range available. Our acquisition also gives us the opportunity to co-develop complementary antibodies, ELISAs and kits from R&D Systems and complementary inhibitors and substrates from Tocris Bioscience. All Boston Biochem specialized tools continue to be developed, produced, and characterized in-house with a commitment to affordability and excellence.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access